Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
1don MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...
Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results